Filter By Category

Insights

Empowering Health Workers When Power is Unreliable

Global Good recently donated three INCUDIGIT-SV 30 biological culture incubators to the Governor’s office of Lagos State.

Read More

Insights

Watch the Webinar: Artificial Intelligence for Identifying Cervical Precancer

Global Good recently conducted a World Cancer Day 2019 webinar called Artificial Intelligence for Identifying Cervical Precancer, which explores how a new Automated Visual Evaluation (AVE) technique will potentially increase access to quality cervical cancer screening worldwide.

Read More

Insights

Why We Need Innovative Nuclear Energy

Intellectual Ventures founder and CEO Nathan Myhrvold illuminates why people and the planet need every source of reliable, carbon-free energy we can get.

Read More

Insights

Why We’re Reinventing the Door and Window

A new study by Global Good and its partners explores how reinventing two common household items—the window and door—could save lives by keeping pesky mosquitoes out of African homes.

Read More

Press Releases

Intellectual Ventures Expands Licensing Relationship with Dominion Harbor Enterprises

Recent success in licensing the IV portfolio to regional banks results in increased licensing opportunities.

Read More

Press Releases

Intellectual Ventures, Desmarais Team up to Drive Licensing and Enforcement of IV Patent Portfolio

Under this agreement, Desmarais will have visibility into IV’s patent portfolio and will work with IV executives to identify licensing and enforcement opportunities with companies currently unlicensed to IV’s portfolio.

Read More

Press Releases

Access Bio and Global Good collaborate for five-fold improvement in pLDH marker detection for HRP2-deleted P. falciparum

New, high-impact detection kit will prove useful for both P. falciparum and P. vivax species.

Read More

Press Releases

Intellectual Ventures Reaches Settlement, License Agreement with HCC

“With this license, we are one step closer to ending the unlicensed use of our technology by the insurance industry,” said Mathen Ganesan, executive vice president, Invention Investment Fund at Intellectual Ventures.

Read More

Publications

New Prototype Screened Doors and Windows for Excluding Mosquitoes from Houses: A Pilot Study in Rural Gambia.

With partners, Global Good is redesigning the window and door to keep deadly mosquitoes out of African homes.

Read More

Publications

Automated microscopy for routine malaria diagnosis: a field comparison on Giemsa-stained blood films in Peru.

Autoscope was tested in the Iquitos region of Peru in 2016 at two peripheral health facilities, with routine microscopy and PCR as reference standards. The main outcome measures include sensitivity and specificity of diagnosis of malaria from Giemsa-stained blood films, using PCR as reference.

Read More

Publications

Polydisperse emulsion digital assay to enhance time to detection and extend dynamic range in bacterial cultures enabled by a statistical framework.

Microbiological culture remains the most sensitive method for detecting viable and infectious bacteria, but these methods often require at least 24 hours to visibly identify bacterial growth.

Read More

Publications

Improving Lateral Flow Assay Performance Using Computational Modeling.

Here, we review the principles underpinning lateral flow assays and the historical evolution of theory to predict their performance.

Read More

Media Coverage

LexSet Takes Home Two AR/VR Industry Awards

AR Post

2017 spinout LexSet is already collecting award wins, recognized for their exemplary work in AR and VR technology by AWE USA and the GS1Connect Pitch Competition. Congratulations to the team!

Read More

Media Coverage

Wine-Spilling Robots Provide a New Way to Look at Food

Bloomberg

Bloomberg recently dove into the science and technology behind Nathan Myhrvold’s photography and his book, The Photography of Modernist Cuisine.

Read More

Media Coverage

100 Best Companies to Work For 2019: Midsize Companies

Seattle Business Magazine

Spinouts Xinova and Pivotal Commware were named to Seattle Business Magazine’s 100 Best Companies to Work For!

Read More

Media Coverage

‘It could be me, it could be us’: Why this researcher wants accessible cervical cancer screening

Crosscut

Research scientist Corrie Ortega recently sat down with Crosscut to discuss her work at IV, her career trajectory, and passion for global health.

Read More

Popular Tags

inventors invention global good nathan myhrvold stem iv lab secondary market patent reform licensing historical global health adriane brown u.s. economy invention science fund litigation edward jung commercialization patent policy portfolio partner idf spinouts c-suite customer